Journal article · 2020 · Open access

Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey

on behalf of the Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT), Anke Verlinden, Małgorzata Mikulska, Nina Simone Knelange, Diana Averbuch, Jan Styczyński

Bone Marrow Transplantation, 55(8), 1588–1594 · Published 11 February 2020 · DOI 10.1038/s41409-020-0811-y

Open PDFView at the publisherCite this paper

In brief

“Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey” is a 2020 journal article by on behalf of the Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT) and 5 co-authors, published in Bone Marrow Transplantation. OpenAlex counts 69 citations as of 18 November 2026, which puts it in the top 3% of works published in 2020 by citations. It is open access under a CC BY licence: the full text is free to read at Bone Marrow Transplantation.

Citations
69
Most cited in
2022 (15)
Field-weighted impact
3.13
References
15
Authors
6

Abstract

The aim of this survey was to summarize the current antimicrobial practice in febrile neutropenia and the presence of key aspects of antimicrobial stewardship. A questionnaire was sent to 567 centers, and complete responses were obtained from 194 (34.2%). Fluoroquinolone and co-trimoxazole prophylaxis are used in 57.1% and 89.1%, respectively. In 66.4%, the first-line empirical therapy is piperacillin/tazobactam, whereas 10.9% use carbapenems. Empirical combination therapy is used in stable patients without history of resistant pathogens in 37.4%. De-escalation to monotherapy is performed within 3 days in 35.3% and after 10 days in 19.1%. Empirical addition of a glycopeptide is performed when fever persists more than 2-3 days in 60.8%. Empirical escalation to a broader spectrum agent is performed when fever persists more than 3-5 days in 71.4%. In case of positive blood cultures with a susceptible pathogen and uncomplicated presentation, 76.7% of centers de-escalate and 36.6% discontinue before neutrophil recovery. In fever of unknown origin with uncomplicated presentation, 54.1% of centers de-escalate and 49.5% discontinue before neutrophil recovery. Recommendations put forward in the ECIL guidelines are not widely implemented in clinical practice. Specific problems include overuse of carbapenems and combination therapy and unjustified addition of glycopeptides without further de-escalation or discontinuation.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

on behalf of the Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT), Verlinden, A., Mikulska, M., Knelange, N. S., Averbuch, D., & Styczyński, J. (2020). Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey. Bone Marrow Transplantation, 55(8), 1588–1594. https://doi.org/10.1038/s41409-020-0811-y

MLA 9

on behalf of the Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT), et al. “Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey.” Bone Marrow Transplantation, vol. 55, no. 8, 2020, pp. 1588–1594. https://doi.org/10.1038/s41409-020-0811-y.

Chicago

on behalf of the Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT), Anke Verlinden, Małgorzata Mikulska, Nina Simone Knelange, Diana Averbuch, and Jan Styczyński. 2020. “Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey.” Bone Marrow Transplantation 55 (8): 1588–1594. https://doi.org/10.1038/s41409-020-0811-y.

Harvard

on behalf of the Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT) et al. (2020) ‘Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey’, Bone Marrow Transplantation, 55(8), pp. 1588–1594. doi:10.1038/s41409-020-0811-y.

IEEE

on behalf of the Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT), A. Verlinden, M. Mikulska, N. S. Knelange, D. Averbuch, and J. Styczyński, “Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey,” Bone Marrow Transplantation, vol. 55, no. 8, pp. 1588–1594, 2020, doi: 10.1038/s41409-020-0811-y.

BibTeX

@article{onbehalfoftheinfectiousdiseasesworkingpartyidwpoftheeuropeangroup2020current,
  title     = {{Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey}},
  author    = {on behalf of the Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT) and Verlinden, Anke and Mikulska, Małgorzata and Knelange, Nina Simone and Averbuch, Diana and Styczyński, Jan},
  journal   = {Bone Marrow Transplantation},
  year      = {2020},
  volume    = {55},
  number    = {8},
  pages     = {1588--1594},
  doi       = {10.1038/s41409-020-0811-y},
  url       = {https://doi.org/10.1038/s41409-020-0811-y}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202055
202166
20221515
202377
20241515
20251212
202699

Its field-weighted citation impact is 3.13: it has been cited 3.13 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections

  • febrile neutropenia
  • antimicrobial stewardship
  • empirical antibiotic therapy
  • fluoroquinolone prophylaxis
  • cotrimoxazole prophylaxis
  • piperacillin-tazobactam
  • antibiotic de-escalation
  • fever of unknown origin

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

on behalf of the Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT), Verlinden, A., Mikulska, M., Knelange, N. S., Averbuch, D., & Styczyński, J. (2020). Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey. Bone Marrow Transplantation, 55(8), 1588–1594. https://doi.org/10.1038/s41409-020-0811-y

How many times has this paper been cited?

69 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Bone Marrow Transplantation: sign in and open the PDF from this page.

Who wrote this paper?

on behalf of the Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT), Anke Verlinden, Małgorzata Mikulska, Nina Simone Knelange, Diana Averbuch, Jan Styczyński.

What is the DOI of this paper?

10.1038/s41409-020-0811-y, permanently at https://doi.org/10.1038/s41409-020-0811-y. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.